{"title": "Life Sciences \u2013 News von XING und Handelszeitung: Informationen und Neuigkeiten | XING", "author": null, "url": "https://www.xing.com/pages/life-sciences-news-von-xing-und-handelszeitung", "hostname": "xing.com", "description": "Interessiert, was sich bei Roche, Novartis, Pfizer oder Gilead tut, welches Biotech-Startup gerade eine Finanzierungsrunde abgeschlossen hat und an welcher Schweizer Universit\u00e4t gerade Medizingeschichte geschrieben wird? Dann sind Sie bei \"Life Sciences \u2013 News von XING und Handelszeitung\", dem Newsletter f\u00fcr Pharma, Biotech, Medtech und Medizin richtig. Der Newsletter wird kuratiert von den beiden Handelszeitungs-Journalisten Seraina Ursina Gross und Ralph P\u00f6hner. Seraina schreibt \u00fcber die Biotech-Industrie. Sie lebt in Basel. Ralph leitet die Online-Redaktion und ist Chef\u00f6konom der Handelszeitung, Die Nachrichten werden von unterschiedlichen, digitalen Nachrichtenquellen ausgew\u00e4hlt. XING ist f\u00fcr den Inhalt der Nachrichten nicht verantwortlich und nimmt durch die Ver\u00f6ffentlichung und Auswahl der Ausschnittstexte inklusive Links zu den Nachrichtenquellen keine Bewertung oder Unterst\u00fctzung f\u00fcr ggf. enthaltene Produkte, politische Parteien oder Firmen vor.", "sitename": "XING", "date": "2021-09-09", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[Gesponsert werden vor allem M\u00e4nner](https://www.handelszeitung.ch/unternehmen/gesponsert-werden-vor-allem-manner) [M\u00e4nner bilden mit 62 Prozent die Mehrheit der Bez\u00fcger von Pharmageldern. Misst man es in Betr\u00e4gen, so fliessen gar 71 Prozent an sie.](https://www.handelszeitung.ch/unternehmen/gesponsert-werden-vor-allem-manner) [www.handelszeitung.ch](https://www.handelszeitung.ch/unternehmen/gesponsert-werden-vor-allem-manner)\nAm Puls von Pharma, Biotech, Medtech & Medizin\n1.960 Follower\nInteressiert, was sich bei Roche, Novartis, Pfizer oder Gilead tut, welches Biotech-Startup gerade eine Finanzierungsrunde abgeschlossen hat und an welcher Schweizer Universit\u00e4t gerade Medizingeschichte geschrieben wird? Dann sind Sie bei \"Life Sciences \u2013 News von XING und Handelszeitung\", dem Newsletter f\u00fcr Pharma, Biotech, Medtech und Medizin richtig. Der Newsletter wird kuratiert von den beiden Handelszeitungs-Journalisten Seraina Ursina Gross und Ralph P\u00f6hner. Seraina schreibt \u00fcber die Biotech-Industrie. Sie lebt in Basel. Ralph leitet die Online-Redaktion und ist Chef\u00f6konom der Handelszeitung, Die Nachrichten werden von unterschiedlichen, digitalen Nachrichtenquellen ausgew\u00e4hlt. XING ist f\u00fcr den Inhalt der Nachrichten nicht verantwortlich und nimmt durch die Ver\u00f6ffentlichung und Auswahl der Ausschnittstexte inklusive Links zu den Nachrichtenquellen keine Bewertung oder Unterst\u00fctzung f\u00fcr ggf. enthaltene Produkte, politische Parteien oder Firmen vor.", "language": null, "image": "https://www.xing.com/imagecache/public/scaled_original_image/eyJ1dWlkIjoiZTE5YjIxMGEtNWMzMi00NjA5LWFkOWQtMTdjNzNkMzc1YmE1IiwiYXBwX2NvbnRleHQiOiJlbnRpdHktcGFnZXMiLCJtYXhfd2lkdGgiOjMyMCwibWF4X2hlaWdodCI6MzIwfQ?signature=e04c2dec72787da8c51b44cd46b65e50b60cce1d054c44e19cde67740cdae91a", "pagetype": "website", "links": ["/", "/", "https://login.xing.com/?dest_url=/pages/life-sciences-news-von-xing-und-handelszeitung", "https://login.xing.com/?dest_url=/pages/life-sciences-news-von-xing-und-handelszeitung", "/", "https://www.handelszeitung.ch/unternehmen/gesponsert-werden-vor-allem-manner", "https://www.handelszeitung.ch/unternehmen/gesponsert-werden-vor-allem-manner", "https://www.handelszeitung.ch/unternehmen/gesponsert-werden-vor-allem-manner", "https://www.handelszeitung.ch/unternehmen/gesponsert-werden-vor-allem-manner", "https://www.handelszeitung.ch/unternehmen/gesponsert-werden-vor-allem-manner", "https://www.handelszeitung.ch/unternehmen/jetzt-sprechen-die-top-bezuger-unter-den-arzten", "https://www.handelszeitung.ch/unternehmen/jetzt-sprechen-die-top-bezuger-unter-den-arzten", "https://www.handelszeitung.ch/unternehmen/jetzt-sprechen-die-top-bezuger-unter-den-arzten", "https://www.handelszeitung.ch/unternehmen/jetzt-sprechen-die-top-bezuger-unter-den-arzten", "https://www.handelszeitung.ch/unternehmen/jetzt-sprechen-die-top-bezuger-unter-den-arzten", "https://www.handelszeitung.ch/unternehmen/die-arzte-und-das-liebe-geld", "https://www.handelszeitung.ch/unternehmen/die-arzte-und-das-liebe-geld", "https://www.handelszeitung.ch/unternehmen/die-arzte-und-das-liebe-geld", "https://www.handelszeitung.ch/unternehmen/die-arzte-und-das-liebe-geld", "https://www.handelszeitung.ch/unternehmen/die-arzte-und-das-liebe-geld", "https://www.handelszeitung.ch/unternehmen/die-pharmaindustrie-bezahlt-182-millionen-an-arzte-und-spitaler", "https://www.handelszeitung.ch/unternehmen/die-pharmaindustrie-bezahlt-182-millionen-an-arzte-und-spitaler", "https://www.handelszeitung.ch/unternehmen/die-pharmaindustrie-bezahlt-182-millionen-an-arzte-und-spitaler", "https://www.handelszeitung.ch/unternehmen/die-pharmaindustrie-bezahlt-182-millionen-an-arzte-und-spitaler", "https://www.handelszeitung.ch/unternehmen/die-pharmaindustrie-bezahlt-182-millionen-an-arzte-und-spitaler", "https://www.beobachter.ch/gesundheit/medizin-krankheit/eine-alternative-zur-mrna-impfung-so-funktioniert-der-corona-impfstoff", "https://www.beobachter.ch/gesundheit/medizin-krankheit/eine-alternative-zur-mrna-impfung-so-funktioniert-der-corona-impfstoff", "https://www.beobachter.ch/gesundheit/medizin-krankheit/eine-alternative-zur-mrna-impfung-so-funktioniert-der-corona-impfstoff", "https://www.beobachter.ch/gesundheit/medizin-krankheit/eine-alternative-zur-mrna-impfung-so-funktioniert-der-corona-impfstoff", "https://www.beobachter.ch/gesundheit/medizin-krankheit/eine-alternative-zur-mrna-impfung-so-funktioniert-der-corona-impfstoff", "https://www.cash.ch/news/top-news/biotech-cassiopea-und-sun-pharma-bringen-akne-mittel-im-vierten-quartal-auf-den-markt-1817540", "https://www.cash.ch/news/top-news/biotech-cassiopea-und-sun-pharma-bringen-akne-mittel-im-vierten-quartal-auf-den-markt-1817540", "https://www.cash.ch/news/top-news/biotech-cassiopea-und-sun-pharma-bringen-akne-mittel-im-vierten-quartal-auf-den-markt-1817540", "https://www.cash.ch/news/top-news/biotech-cassiopea-und-sun-pharma-bringen-akne-mittel-im-vierten-quartal-auf-den-markt-1817540", "https://www.cash.ch/news/top-news/biotech-cassiopea-und-sun-pharma-bringen-akne-mittel-im-vierten-quartal-auf-den-markt-1817540", "https://www.handelszeitung.ch/politik/impfen-ist-big-business", "https://www.handelszeitung.ch/politik/impfen-ist-big-business", "https://www.handelszeitung.ch/politik/impfen-ist-big-business", "https://www.handelszeitung.ch/politik/impfen-ist-big-business", "https://www.handelszeitung.ch/politik/impfen-ist-big-business", "https://www.handelszeitung.ch/unternehmen/ten23-das-geschaft-mit-den-trilliarden", "https://www.handelszeitung.ch/unternehmen/ten23-das-geschaft-mit-den-trilliarden", "https://www.handelszeitung.ch/unternehmen/ten23-das-geschaft-mit-den-trilliarden", "https://www.handelszeitung.ch/unternehmen/ten23-das-geschaft-mit-den-trilliarden", "https://www.handelszeitung.ch/unternehmen/ten23-das-geschaft-mit-den-trilliarden", "https://www.xing.com/news/articles/link/3921711?xng_share_origin=web", "https://www.xing.com/news/articles/link/3921711?xng_share_origin=web", "https://www.xing.com/news/articles/link/3921711?xng_share_origin=web", "https://www.xing.com/news/articles/link/3921711?xng_share_origin=web", "https://www.xing.com/news/articles/link/3921711?xng_share_origin=web", "https://www.xing.com/news/articles/link/3907825?xng_share_origin=web", "https://www.xing.com/news/articles/link/3907825?xng_share_origin=web", "https://www.xing.com/news/articles/link/3907825?xng_share_origin=web", "https://www.xing.com/news/articles/link/3907825?xng_share_origin=web", "https://www.xing.com/news/articles/link/3907825?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863541?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863541?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863541?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863541?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863541?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863450?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863450?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863450?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863450?xng_share_origin=web", "https://www.xing.com/news/articles/link/3863450?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862267?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862267?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862267?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862267?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862267?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862265?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862265?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862265?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862265?xng_share_origin=web", "https://www.xing.com/news/articles/link/3862265?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853907?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853907?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853907?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853907?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853907?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853905?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853905?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853905?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853905?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853905?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853904?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853904?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853904?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853904?xng_share_origin=web", "https://www.xing.com/news/articles/link/3853904?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849816?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849816?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849816?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849816?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849816?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849815?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849815?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849815?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849815?xng_share_origin=web", "https://www.xing.com/news/articles/link/3849815?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847972?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847972?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847972?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847972?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847972?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847199?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847199?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847199?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847199?xng_share_origin=web", "https://www.xing.com/news/articles/link/3847199?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844857?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844857?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844857?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844857?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844857?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844863?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844863?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844863?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844863?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844863?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844851?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844851?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844851?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844851?xng_share_origin=web", "https://www.xing.com/news/articles/link/3844851?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834922?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834922?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834922?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834922?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834922?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834830?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834830?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834830?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834830?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834218?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834218?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834218?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834218?xng_share_origin=web", "https://www.xing.com/news/articles/link/3834218?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833606?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833606?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833606?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833606?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833606?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833604?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833604?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833604?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833604?xng_share_origin=web", "https://www.xing.com/news/articles/link/3833604?xng_share_origin=web", "https://www.xing.com/news/articles/link/3822128?xng_share_origin=web", "https://www.xing.com/news/articles/link/3822128?xng_share_origin=web", "https://www.xing.com/news/articles/link/3822128?xng_share_origin=web", "https://www.xing.com/news/articles/link/3822128?xng_share_origin=web", "https://www.xing.com/news/articles/link/3822128?xng_share_origin=web", "https://www.new-work.se/de", "https://www.new-work.se/de/karriere/", "https://www.new-work.se/de/investor-relations/", "https://www.new-work.se/de/newsroom/", "https://nwx.new-work.se", "https://faq.xing.com/de", "https://tech.new-work.se/", "https://mobile.xing.com/de/", "https://www.xing.com/upsell/premium_offers?reagent=uplt_98", "https://www.xing.com/upsell/projobs?reagent=uplt_205", "https://www.xing.com/people/", "https://www.xing.com/jobs", "https://www.xing.com/news", "https://www.xing.com/companies", "https://coaches.xing.com/", "https://recruiting.xing.com/de/", "https://www.hallofreelancer.com/", "https://www.xing.com/xam/personal/ads", "https://werben.xing.com", "https://lebenslauf.com/", "https://anschreiben.com/", "https://bewerbung.com/", "https://www.kununu.com/", "https://praktikum-guide.com/", "https://www.xing.com/karriere-ratgeber", "/", "https://www.xing.com/legalnotice", "https://www.xing.com/terms", "https://privacy.xing.com/de", "https://privacy.xing.com/de/datenschutzerklaerung", "https://www.xing.com/support/contact/memberships", "/language?sc_o=navigation_footer"]}